Lv1
10 积分 2024-12-03 加入
Abstract Supplement ACR Convergence 2024
4天前
已完结
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]
15天前
已完结
TEZEPELUMAB REDUCED OCS USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA: PHASE 3B WAYFINDER INTERIM Results:
1个月前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
1个月前
已完结
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
4个月前
已完结
皖公网安备34019202002308
